Home LiteratureArticle Details
PMID: 9185136 Published · ppublish English Journal Article Review

The enduring pneumococcus: unfinished business and opportunities for the future.

Microbial drug resistance (Larchmont, N.Y.) ·Vol. 3 ·No. 2 ·1997-00-00 ·Pages 111-5

Austrian R

Abstract

暂无摘要

MeSH Terms
Animals Anti-Bacterial Agents/pharmacology,therapeutic use Bacterial Vaccines/therapeutic use Drug Resistance, Microbial Humans Pneumococcal Infections/drug therapy,immunology,prevention & control Streptococcus pneumoniae/drug effects,physiology
Chemicals
Anti-Bacterial Agents Bacterial Vaccines
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Austrian R
Department of Molecular and Cellular Engineering, University of Pennsylvania, School of Medicine, Philadelphia 19104-6088, USA.
Article Info
Journal
Microbial drug resistance (Larchmont, N.Y.)
Abbr.
Microb Drug Resist
ISSN
1076-6294
DOI
10.1089/mdr.1997.3.111
Published
1997-00-00
Pages
111-5
Language
English
Region
United States
NLM ID
9508567
Subset
IM
External Links
PubMed source DOI: 10.1089/mdr.1997.3.111 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2